Robert Yoder
Corporate Officer/Principal chez TREVENA, INC.
Fortune : 73 083 $ au 31/03/2024
Profil
Robert T.
Yoder is currently the Chief Business Officer & Senior Vice President at Trevena, Inc. Prior to his current position, he worked as the Head of Information Technology at Orexigen Therapeutics, Inc. from 2015 to 2018.
Mr. Yoder holds an MBA from Emory University and an undergraduate degree from Dickinson College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TREVENA, INC.
0,87% | 14/12/2023 | 158 877 ( 0,87% ) | 73 083 $ | 31/03/2024 |
Postes actifs de Robert Yoder
| Sociétés | Poste | Début |
|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 10/12/2018 |
Anciens postes connus de Robert Yoder
| Sociétés | Poste | Fin |
|---|---|---|
| OREXIGEN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2018 |
Formation de Robert Yoder
| Emory University | Masters Business Admin |
| Dickinson College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
